TXNRD2 and dilated cardiomyopathy: Txnrd2 deletion in mice is embryonically lethal at day 13 as a consequence of a combination of cardiac and hematopoietic defects, with cardiac-specific ablation resulting in a fatal dilated cardiomyopathy (18).